HCA Healthcare (NYSE:HCA – Get Rating) issued an update on its FY 2022 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of $16.400-$17.600 for the period, compared to the Thomson Reuters consensus estimate of $18.930. The company issued revenue guidance of $59.50 billion-$61.50 billion, compared to the consensus revenue estimate […]